Dennis M. Fenton

Executive V.P., Operations, Amgen.

Companies

First Tracks Biotherapeutics, Inc.Board member Apr 1, 2026 to now¹
ANAPTYSBIO, INCBoard member Mar 6, 2018 to now²
HospiraBoard member Aug 2, 2012 to Sep 3, 2015³
AmgenExecutive V.P., Operations Jan 23, 2006 to Jun 5, 2007⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

First Tracks Biotherapeutics, Inc. TRAX10,995 shares⁵$397.9K at $36.19Jun 15, 2026
ANAPTYSBIO, INC ANAB4,965 shares⁶$235.4K at $47.42Jun 18, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 15, 2026Exercised options 6,030 shares of First Tracks Biotherapeutics, Inc.⁵
Jun 18, 2025Sold 3,015 shares at $23.97 of ANAPTYSBIO, INC⁶
Jun 15, 2025Exercised options 6,030 shares of ANAPTYSBIO, INC⁷
Jun 21, 2024Sold 1,950 shares at $23.17 of ANAPTYSBIO, INC⁸
Jun 15, 2024Exercised options 3,900 shares of ANAPTYSBIO, INC⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARFirst Tracks Biotherapeutics, Inc., Board member
2
SEC EDGARANAPTYSBIO, INC, Board member
3
SEC EDGARHospira, Board member
4
SEC EDGARAmgen, Executive V.P., Operations
5
SEC EDGARFirst Tracks Biotherapeutics, Inc. shares after the filing of Jun 15, 2026
6
SEC EDGARANAPTYSBIO, INC shares after the filing of Jun 18, 2025
7
SEC EDGARForm 4 filed Jun 17, 2025
8
SEC EDGARForm 4 filed Jun 24, 2024
9
SEC EDGARForm 4 filed Jun 18, 2024